Development of COVID-19 antiviral coatings for N95 respirators

开发用于 N95 呼吸器的 COVID-19 抗病毒涂层

• 批准号: 554383-2020
• 负责人: Musselman, Kevin
• 金额: $ 3.64万
• 依托单位: University of Waterloo
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=705424
• 关键词: Development; COVID; 19; antiviral; coatings

During the outbreak of COVID-19, personal protective equipment (PPE) has played a critical role as the first line of defense between the virus and people, particularly healthcare workers. This equipment, however, is not typically treated to have antiviral properties. Since the virus is viable in aerosols and on surfaces for days, contaminated PPE has become another potential source of virus infection, posing a risk to healthcare workers and others handling the waste. In this project, antiviral coatings that are effective for COVID-19 will be developed. This will include studies on virus viability and altered protein synthesis, after exposure to different coating materials. In collaboration with Eclipse Automation, manufacturing processes will be developed to deposit these antiviral coatings on the fabrics that are employed as the outer layer on N95 respirators. The developed technology will be transferred to industry to provide enhanced PPE for Canadians.

在 COVID-19 爆发期间，个人防护装备 (PPE) 发挥了至关重要的作用 病毒与人（尤其是医护人员）之间的第一道防线。这个设备， 然而，通常不具有抗病毒特性。由于该病毒可以在气溶胶和空气中存活 连续几天，受污染的个人防护装备已成为病毒感染的另一个潜在来源，构成了 医护人员和其他处理废物的人面临风险。在该项目中，将开发对 COVID-19 有效的抗病毒涂层。这将包括在暴露于不同涂层材料后对病毒活力和蛋白质合成改变的研究。与 Eclipse Automation 合作，将开发制造工艺，将这些抗病毒涂层沉积在用作 N95 呼吸器外层的织物上。开发的技术将转移到工业界，为加拿大人提供增强的个人防护装备。